Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma
Previous
Previous
Executive Holidays: Cynt Marshall, Chad Houser, Chris Kelly, Peter Brodsky, and More
Next
Next